Enliven Therapeutics ELVN
NASDAQ ELVN
$46.21 +0.37 (+0.81%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Tax Provisions (2024)

Updated

Enliven Therapeutics' Tax Provisions came in at $232,000 for FY2024.

Analysis

Enliven Therapeutics (ELVN) Tax Provisions (2024) Analysis & Trends

  • Per Business Quant, earlier years put Tax Provisions at $88,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Enliven Therapeutics 3.36 Bn 3.36 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 232,000.00
API Access

Enliven Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=ELVN&period=max&api_key=YOUR_API_KEY